EHD2 and central nervous system cancer: Under-expression of EHD2 mRNA and EHD2 protein has been observed in different cancers, including esophageal squamous cells carcinoma, breast cancer, glioma, and serous ovarian cancers compared to normal tissue samples [18–21].